Depressive symptoms in late life lead to a high economic burden for nations which is not explained by costs for depressive symptom treatment. Strategies for improvement of diagnostic validity and treatment success of depressive symptoms in late life may have an effect on economic burden for societies.
No takes yet. Share an insight, caveat, or question.
Luppa et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: